GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Jo-Jo Drugstores Inc (FRA:7QL) » Definitions » Risk Assessment

China Jo-Jo Drugstores (FRA:7QL) Risk Assessment


View and export this data going back to 2010. Start your Free Trial

What is China Jo-Jo Drugstores Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of China Jo-Jo Drugstores is: No Data: Cannot be evaluated.


Competitive Comparison of China Jo-Jo Drugstores's Risk Assessment

For the Pharmaceutical Retailers subindustry, China Jo-Jo Drugstores's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Jo-Jo Drugstores's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Jo-Jo Drugstores's Risk Assessment distribution charts can be found below:

* The bar in red indicates where China Jo-Jo Drugstores's Risk Assessment falls into.



China Jo-Jo Drugstores  (FRA:7QL) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


China Jo-Jo Drugstores Risk Assessment Related Terms

Thank you for viewing the detailed overview of China Jo-Jo Drugstores's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


China Jo-Jo Drugstores (FRA:7QL) Business Description

Traded in Other Exchanges
Address
386 Shangtang Road, Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Zhejiang Province, Hangzhou, CHN, 310008
China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, Drug wholesale, and Herb farming. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.

China Jo-Jo Drugstores (FRA:7QL) Headlines

No Headlines